Rheumatology

Rheumatology Network's Top 5: November 26, 2021

November 26, 2021

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending November 26, 2021.

Ana-Maria Orbai, MD, FACR, MHS: Guselkumab Improves PROMIS-29 Scores in Patients With Psoriatic Arthritis

November 25, 2021

Ana-Maria Orbai, MD, FACR, MHS, explains how guselkumab improved PROMIS-29 scores in patients with psoriatic arthritis.

Overdrive Podcast: Unmet Patient Needs in Rheumatic Disease

November 24, 2021

Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases and Janssen’s role in scientific innovation that allows patients to live their lives unburdened by disease.

Robert Terkeltaub, MD: Safety and Efficacy of Tigulixostat in Gout Treatment

November 23, 2021

Robert Terkeltaub, MD, explains the results from a phase 2, dose-finding study to determine the safety and efficacy of tigulixostat in patients with gout.

Rheumatoid Arthritis Quiz: JAK Inhibitors

November 23, 2021

Janus kinase (JAK) inhibitors are the newest class of drugs used to treat rheumatoid arthritis. How much do you know about these drugs? Test your knowledge with this quiz.

Courtney Wells, PhD, MPH, MSW: Impact of COVID-19 on the Quality of Life of Patients with Rheumatic Disease

November 22, 2021

Courtney Wells, PhD, MPH, MSW, discusses the impact of the pandemic on the quality of life of patients with rheumatic conditions, with an emphasis on perceived risk and decision making.

Robert F. Spiera, MD: Mycophenolate Treatment Is Associated with Improved Outcomes in Trial of Lenabasum in Patients With Systemic Sclerosis

November 22, 2021

Robert F Spiera, MD, explains background mycophenolate treatment and its associated improved outcomes in patients with systemic sclerosis receiving lenabasum.